Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Shares Issued (2016 - 2025)

Jaguar Health (JAGX) has disclosed Shares Issued for 11 consecutive years, with -$2.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued fell 107.16% to -$2.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $4.3 million, a 84.5% decrease, with the full-year FY2024 number at $30.8 million, up 2391.91% from a year prior.
  • Shares Issued was -$2.0 million for Q3 2025 at Jaguar Health, down from $1.5 million in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $27.8 million in Q3 2024 to a low of -$11.6 million in Q3 2022.
  • A 5-year average of $2.3 million and a median of $1.6 million in 2021 define the central range for Shares Issued.
  • Peak YoY movement for Shares Issued: tumbled 554.63% in 2022, then skyrocketed 299900.0% in 2024.
  • Jaguar Health's Shares Issued stood at -$1000.0 in 2021, then crashed by 1159900.0% to -$11.6 million in 2022, then soared by 100.01% to $1000.0 in 2023, then surged by 299900.0% to $3.0 million in 2024, then crashed by 166.37% to -$2.0 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Shares Issued are -$2.0 million (Q3 2025), $1.5 million (Q2 2025), and $1.8 million (Q1 2025).